- Investing Ideas
- /
- Egyptian Pharmaceuticals & Biotech Undervalued based on future growth
Egyptian Pharmaceuticals & Biotech Undervalued based on future growth
Results
2
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
2 companies
Egyptian International Pharmaceutical Industries
Market Cap: ج.م13.5b
Manufactures and sells pharmaceutical ampoules in Egypt and internationally.
PHAR
ج.م80.00
7D
3.2%
1Y
73.2%
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)
Market Cap: ج.م6.4b
Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.
RMDA
ج.م3.21
7D
-3.6%
1Y
20.4%